Our findings demonstrate that silencing NFKBIA and NFKBID results in a reduction of CRC cell viability following radiotherapy, suggesting that NF-κB activation may enhance the therapeutic efficacy of radiation. This evidence concerns the gene NFKB1 and colorectal carcinoma.